chr17-7668783-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000546.6(TP53):​c.*826G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0505 in 223,876 control chromosomes in the GnomAD database, including 368 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.052 ( 268 hom., cov: 30)
Exomes 𝑓: 0.048 ( 100 hom. )

Consequence

TP53
NM_000546.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.390
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-7668783-C-T is Benign according to our data. Variant chr17-7668783-C-T is described in ClinVar as [Benign]. Clinvar id is 325623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0688 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TP53NM_000546.6 linkc.*826G>A 3_prime_UTR_variant Exon 11 of 11 ENST00000269305.9 NP_000537.3 P04637-1K7PPA8Q53GA5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TP53ENST00000269305 linkc.*826G>A 3_prime_UTR_variant Exon 11 of 11 1 NM_000546.6 ENSP00000269305.4 P04637-1

Frequencies

GnomAD3 genomes
AF:
0.0516
AC:
7572
AN:
146758
Hom.:
264
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0286
Gnomad AMI
AF:
0.107
Gnomad AMR
AF:
0.0454
Gnomad ASJ
AF:
0.0500
Gnomad EAS
AF:
0.0713
Gnomad SAS
AF:
0.0749
Gnomad FIN
AF:
0.117
Gnomad MID
AF:
0.00667
Gnomad NFE
AF:
0.0541
Gnomad OTH
AF:
0.0420
GnomAD4 exome
AF:
0.0479
AC:
3692
AN:
77010
Hom.:
100
Cov.:
0
AF XY:
0.0484
AC XY:
1724
AN XY:
35588
show subpopulations
Gnomad4 AFR exome
AF:
0.0274
AC:
98
AN:
3580
Gnomad4 AMR exome
AF:
0.0374
AC:
88
AN:
2354
Gnomad4 ASJ exome
AF:
0.0478
AC:
232
AN:
4858
Gnomad4 EAS exome
AF:
0.0599
AC:
656
AN:
10948
Gnomad4 SAS exome
AF:
0.0912
AC:
60
AN:
658
Gnomad4 FIN exome
AF:
0.0357
AC:
8
AN:
224
Gnomad4 NFE exome
AF:
0.0471
AC:
2241
AN:
47572
Gnomad4 Remaining exome
AF:
0.0476
AC:
302
AN:
6344
Heterozygous variant carriers
0
162
325
487
650
812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0518
AC:
7603
AN:
146866
Hom.:
268
Cov.:
30
AF XY:
0.0546
AC XY:
3883
AN XY:
71146
show subpopulations
Gnomad4 AFR
AF:
0.0287
AC:
0.0287237
AN:
0.0287237
Gnomad4 AMR
AF:
0.0455
AC:
0.0455177
AN:
0.0455177
Gnomad4 ASJ
AF:
0.0500
AC:
0.05
AN:
0.05
Gnomad4 EAS
AF:
0.0719
AC:
0.0718837
AN:
0.0718837
Gnomad4 SAS
AF:
0.0753
AC:
0.0752665
AN:
0.0752665
Gnomad4 FIN
AF:
0.117
AC:
0.116692
AN:
0.116692
Gnomad4 NFE
AF:
0.0541
AC:
0.0540937
AN:
0.0540937
Gnomad4 OTH
AF:
0.0495
AC:
0.0495495
AN:
0.0495495
Heterozygous variant carriers
0
340
680
1021
1361
1701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0555
Hom.:
34
Bravo
AF:
0.0456
Asia WGS
AF:
0.126
AC:
436
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Li-Fraumeni syndrome 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 18, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Jun 18, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.2
DANN
Benign
0.74
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17884306; hg19: chr17-7572101; API